Patients with specific biological ( body mass index @ kg/m , elevated plasma levels of high-sensitivity C-reactive protein or @-hydroxy-@-nonenal , low S-adenosylmethionine/S-adenosylhomocysteine ratio ) and genetic markers at baseline had significantly ( P @ ) greater pooled mean change from baseline on the HDRS-@ with L-methylfolate versus placebo .